Assessing the reporting quality of randomized controlled trials on COVID-19 vaccines: a systematic review
This systematic review evaluated the reporting quality of COVID-19 vaccine randomized controlled trials (RCTs). Relevant RCTs published between July 20, 2020 and June 11, 2021 were identified in the PubMed database by two independent reviewers. Study quality was evaluated with the 2010 AND 2001 Cons...
Saved in:
Main Authors: | Guanran Zhang (Author), Sirui Kuang (Author), Xiaoli Zhang (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comprehensive assessment of the impact of intravitreal faricimab on retinal diseases: A systematic review, meta-analysis, and trial sequential analysis
by: Guanran Zhang, et al.
Published: (2024) -
Assessment of the reporting quality of randomised controlled trials of massage
by: Xuan Zhang, et al.
Published: (2021) -
The quality of reporting of randomized controlled trials of HuatuoZaizao pill for stroke
by: Xiao-Jie Zhang, et al.
Published: (2023) -
Antiviral Treatment in COVID-19 Outpatients: A Systematic Review of Randomized Controlled Trials
by: David Setyo Budi, et al.
Published: (2022) -
Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial
by: Tao Huang, et al.
Published: (2024)